Status:
COMPLETED
Epidemiology of Gout in French Polynesia
Lead Sponsor:
Lille Catholic University
Collaborating Sponsors:
Variant Bio, Inc.
University of Birmingham
Conditions:
Gout
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Gout is a chronic disease caused by the deposit of monosodium urate (MSU) crystals in body tissues secondary to hyperuricemia. Patients with gout suffer severe attacks of acute joint pain. As the dise...
Detailed Description
International genomic studies conducted in populations with hyperuricemia and gout have identified a number of associated alleles. The strength of the association between a given allele and gout (or h...
Eligibility Criteria
Inclusion
- Living in Tahiti, Moorea, Tahaa-Raiatea, Tikehau, Nuku Hiva, Mangareva, Rurutu
- Agreeing to participate in the study
Exclusion
- Homeless
- Living in communities (military camp, hospices, university residence, ...)
- Unable to answer questionnaires
- Under guardianship
Key Trial Info
Start Date :
April 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 16 2021
Estimated Enrollment :
1088 Patients enrolled
Trial Details
Trial ID
NCT04812886
Start Date
April 29 2021
End Date
August 16 2021
Last Update
September 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de la Polynésie Française
Pirae, French Polynesia, 98713